Scilex Holding
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
960 San Antonio Rd, Palo Alto, Californi...Phone Number
(650) 516-4310Website
www.scilexholding.comRevenue
$33.9 MillionStock Symbol
SCLXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Scilex Holding
Scilex is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.Explore more
Scilex Holding Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scilex Holding your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Scilex Holding has recently received funding, and reach out quickly before it becomes old news!
Scilex Holding, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Scilex Holding had a recent Job posting/layoffs
Product Launch: Get notified when Scilex Holding launches new products
Earning: See what the market has to say on Scilex Holding recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Scilex Holding
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Scilex Holding has new funding data
Check out if Scilex Holding is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Scilex Holding
Compare insights from companies similar to Scilex Holding, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Scilex Holding
$33.9M
11-50
Public
$175M
2009
Stephen MaChief Operating Officer, Chief Financial Officer & Senior VP
Company Profile Activity
Activity Insights
Scilex Holding is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Scilex Holding is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Scilex Holding.
Scilex Holding financials insights
Gather financial insights about Scilex Holding, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Debt
$25M
2024
Other Financing Round
$50M
2026
Debt
$100M
Scilex Holding Tech Stack
A closer look at the technologies used by Scilex Holding
Most Recent Scoops
Open Position
Project
Spending/Investment, Funding
Project
Spending/Investment
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Scilex Holding News & Media
Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026
PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that the Dream Bowl I Meme Coin tokens (“Dream Bowl Tokens”) commence trading on the Biconomy Exchange on July 6, 2026.Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)
Binding Term Sheet Supports Growth PlansScilex Holding Company (NASDAQ:SCLX) shares climbed 7% on Monday after the company announced it had signed a binding term sheet for a proposed $100 million strategic investment from Kazakhstan-based private investment firm iHolding Group LLP. Under the proposed agreement, iHolding would acquire approximately 6.Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced the signing of a binding term sheet with iHolding Group LLP ("iHolding"), a private investment group headquartered in Almaty, Republic ofScilex Holding Company Announces Dream Bowl I Meme Coin Tokens to List on Biconomy Exchange as Early as June 23, 2026
PALO ALTO, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced Dream Bowl I Meme Coin tokens (“Dream Bowl Tokens”) to list on Biconomy Exchange as early as June 23, 2026.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scilex Holding
Sign Up For FreeTo access detailed company insights
Scilex is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.... Read More
